SCHEMBL3338387

SCHEMBL3338387

O=C(Cl)CCCCCCCCCCCCl

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.59
ALDH1A1 P00352 5/20 0.59
TP53 P04637 1/20 0.50
FAAH O00519 2/20 0.39
LMNA P02545 2/20 0.38
NFKB1 P19838 1/20 0.38
PMP22 Q01453 1/20 0.38
TDP1 Q9NUW8 3/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33
CES2 O00748 3/20 0.32
CES1 P23141 3/20 0.32
GPR84 Q9NQS5 3/20 0.32
FFAR1 O14842 1/20 0.32
FFAR4 Q5NUL3 1/20 0.32
PPARG P37231 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8624800 1.00 TSHR (0.59) TSHRALDH1A1TP53FAAHLMNA
SCHEMBL8868518 1.00 TSHR (0.59) TSHRALDH1A1TP53FAAHLMNA
SCHEMBL13779603 1.00 TSHR (0.59) TSHRALDH1A1TP53FAAHLMNA
SCHEMBL203285 1.00
SCHEMBL10866381 1.00 TSHR (0.59) TSHRALDH1A1TP53FAAHLMNA
SCHEMBL24243989 1.00 TSHR (0.59) TSHRALDH1A1TP53FAAHLMNA
SCHEMBL4970742 1.00 TSHR (0.59) TSHRALDH1A1TP53FAAHLMNA
SCHEMBL28597284 1.00 TSHR (0.59) TSHRALDH1A1TP53FAAHLMNA
SCHEMBL774984 1.00 TSHR (0.59) TSHRALDH1A1TP53FAAHLMNA
SCHEMBL77065 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118239859-A Hydrazide compound, rubber composition, and preparation methods and applications thereof 中策橡胶集团股份有限公司 2024-06-25 CN claimed
CN-113795282-A Medical devices comprising covalently bonded heparin coatings 杰美特涂层科技(厦门)有限公司 2021-12-14 CN disclosed
CN-108633275-B Process for purifying phenol 株式会社LG化学 2021-07-27 CN disclosed
US-8916142-B2 Semi-crystalline supramolecular polymers ARKEMA FRANCE (FR) 2014-12-23 US disclosed
EP-1773908-B1 BIODEGRADABLE MULTI-BLOCK POLYMERIC COMPOSITION CAPABLE OF SOL-GEL TRANSITION SAMYANG BIOPHARMACEUTICALS (KR) 2012-09-19 EP disclosed
US-20100135940-A1 SEMI-CRYSTALLINE SUPRAMOLECULAR POLYMERS ARKEMA FRANCE (FR) 2010-06-03 US disclosed
US-7655735-B2 Biodegradable multi-block polymeric composition capable of sol-gel transition and pharmaceutical composition comprising the same SAMYANG CORPORATION (KR) 2010-02-02 US disclosed
US-20070161753-A1 Biodegradable multi-block polymeric composition capable of sol-gel trainsition and pharmaceutical composition comprising the same SAMYANG HOLDINGS CORPORATION (KR) 2007-07-12 US disclosed
EP-1773908-A1 BIODEGRADABLE MULTI-BLOCK POLYMERIC COMPOSITION CAPABLE OF SOL-GEL TRANSITION Samyang Corporation (KR) 2007-04-18 EP disclosed
WO-2006014067-A1 BIODEGRADABLE MULTI-BLOCK POLYMERIC COMPOSITION CAPABLE OF SOL-GEL TRANSITION SAMYANG CORPORATION (KR) 2006-02-09 WO disclosed
EP-0654491-B1 Branched copolyestercarbonates GEN ELECTRIC (US) 2000-03-01 EP disclosed
US-5455323-A Thermoplastic resins containing dihydric phenols and aliphatic dicarboxylic acids as monomers which are randomly separated by units of 1,1,1-tris/4-hydroxyphenol/ ethane, molding materials GENERAL ELECTRIC COMPANY (US) 1995-10-03 US disclosed
EP-0654491-A2 Branched copolyestercarbonates GENERAL ELECTRIC COMPANY (US) 1995-05-24 EP disclosed
US-5356743-A Electrophotographic imaging members containing polyarylamine polyesters XEROX CORPORATION (US) 1994-10-18 US disclosed
US-5212172-A 4-(1-hydroxy-2-substituted amino)ethyl-5-hydroxy-2(5H)-furanones as anti-inflammatory agents ALLERGAN, INC. (US) 1993-05-18 US disclosed
US-5081147-A 4-(1-hydroxy-2-substituted amino)ethyl-5-hydroxy-2(5H)-furanones as anti-inflammatory agents ALLERGAN, INC. (US) 1992-01-14 US disclosed
EP-0155533-B1 MEMBRANES OF NOT ESSENTIALLY CROSS-LINKED POLYMERS BASF Aktiengesellschaft (DE) 1989-11-08 EP disclosed
US-4616041-A Membranes of substantially non-crosslinked organic polymers BASF AKTIENGESELLSCHAFT (DE) 1986-10-07 US disclosed
US-4614546-A INCLUDES AMINE-MODIFIED STARCH AND HYDROPHOBIC COMPOUNDS REACTIVE TO HYDROXY GROUPS BAYER AKTIENGESELLSCHAFT (DE) 1986-09-30 US disclosed
EP-0155533-A2 Membranes of not essentially cross-linked polymers BASF Aktiengesellschaft (DE) 1985-09-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100135940-A1 SEMI-CRYSTALLINE SUPRAMOLECULAR POLYMERS FASN, FFAR3, FFAR2 TSHR 666/4885ALDH1A1 4487/4885TP53 4448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.